Screener
Sana Biotechnology SANA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
FAQ
- What is Sana Biotechnology's EPS (diluted)?
- Sana Biotechnology (SANA) reported EPS (diluted) of -$0.17 in Q1 2026.
- How has Sana Biotechnology's EPS (diluted) changed year-over-year?
- Sana Biotechnology's EPS (diluted) increased by 19.0% year-over-year, from -$0.21 to -$0.17.
- What is the long-term trend for Sana Biotechnology's EPS (diluted)?
- Over 4 years (2021 to 2025), Sana Biotechnology's EPS (diluted) has grown at a -21.1% compound annual growth rate (CAGR), from -$2.50 to -$0.97.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Sana Biotechnology's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude